IL-17A — Drug Target
All drugs that target IL-17A — marketed and clinical-stage. Includes 4 drug classes acting on this target.
Drug classes
IL-17A inhibitor (monoclonal antibody) · IL-17A inhibitor; monoclonal antibody · IL-17A inhibitor monoclonal antibody · Anti-IL-17 monoclonal antibody
Marketed (5)
- Vunakizumab (IL-17A inhibitor) · Fujian Cancer Hospital · IL-17A inhibitor (monoclonal antibody) · Immunology
Vunakizumab is a monoclonal antibody that blocks interleukin-17A (IL-17A), a pro-inflammatory cytokine involved in immune-mediated inflammation. - Secukinumab 150 milligram [Cosentyx] · Professor Mikkel Østergaard · IL-17A inhibitor (monoclonal antibody) · Immunology
Secukinumab is a monoclonal antibody that blocks interleukin-17A (IL-17A), a key inflammatory cytokine involved in immune-mediated diseases. - Proactive TDM-based dosing of ixekizumab · University Hospital, Ghent · IL-17A inhibitor; monoclonal antibody · Immunology
Ixekizumab is an IL-17A inhibitor that blocks interleukin-17A signaling to reduce inflammatory responses in autoimmune conditions. - Ixekizumab Prefilled Syringe · Eli Lilly and Company · IL-17A inhibitor (monoclonal antibody) · Immunology
Ixekizumab is a monoclonal antibody that selectively binds to and neutralizes interleukin-17A (IL-17A), a key inflammatory cytokine involved in immune-mediated diseases. - Secukinumab Auto-Injector · University of Pennsylvania · IL-17A inhibitor (monoclonal antibody) · Immunology
Secukinumab is a monoclonal antibody that blocks interleukin-17A (IL-17A), a key inflammatory cytokine involved in immune-mediated diseases.
Phase 3 pipeline (5)
- JNJ-79635322 · Janssen Research & Development, LLC · IL-17A inhibitor monoclonal antibody · Immunology
JNJ-79635322 is a monoclonal antibody that targets and inhibits IL-17A, a pro-inflammatory cytokine involved in immune-mediated inflammatory diseases. - BCD-263 · Biocad · IL-17A inhibitor (monoclonal antibody) · Immunology / Rheumatology
BCD-263 is a monoclonal antibody that binds to and inhibits IL-17A, a pro-inflammatory cytokine involved in autoimmune and inflammatory diseases. - BCD-063 · Biocad · IL-17A inhibitor monoclonal antibody · Immunology
BCD-063 is a monoclonal antibody that binds to and inhibits IL-17A, a pro-inflammatory cytokine involved in autoimmune and inflammatory diseases. - EU-approved Cosentyx · Celltrion · IL-17A inhibitor (monoclonal antibody) · Immunology / Dermatology / Rheumatology
Cosentyx is a monoclonal antibody that blocks interleukin-17A (IL-17A), a key inflammatory cytokine involved in immune-mediated skin and joint diseases. - Ixekizumab Auto-Injector · Eli Lilly and Company · IL-17A inhibitor (monoclonal antibody) · Immunology
Ixekizumab is a monoclonal antibody that selectively binds to and neutralizes interleukin-17A (IL-17A), a key inflammatory cytokine involved in immune-mediated diseases.
Phase 2 pipeline (1)
- IL-17A antibody · Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Anti-IL-17 monoclonal antibody · Immunology
IL-17A antibody targets the IL-17A receptor